IRF3 and metabolic dysfunction-associated steatotic liver disease: Second, STING-TBK1-IRF3 was activated in the livers of HFD-fed mice and NAFLD patients, and only STING in BMDMs exacerbated the severity of HFD-induced NAFLD.